Amoxicillin and Clavulanate Form Chemically and Immunologically Distinct Multiple Haptenic Structures in Patients
- 21 September 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 29 (10) , 1762-1772
Abstract
Amoxicillin-clavulanate (AC) is one of the most common causes of drug induced liver injury (DILI). The association between AC-DILI and HLA alleles and the detection of drug-specific T cells in patients with AC-DILI indicate that the adaptive immune system is involved in the disease pathogenesis. In this study, mass spectrometric methods were employed to characterize the antigen formed by AC in exposed patients and the antigenic determinants that stimulate T cells. Amoxicillin formed penicilloyl adducts with lysine residues on human serum albumin (HSA) in vitro, with K190 and K199 being the most reactive sites. Amoxicillin-modified K190 and K199 have also been detected in all patients, and more extensive modification was observed in patients exposed to higher doses of amoxicillin. In contrast, the binding of clavulanic acid to HSA was more complicated. Multiple adducts were identified at high concentrations in vitro, including those formed by direct binding of clavulanic acid to lysine residues, novel pyrazine adducts derived from binding to the degradation products of clavulanic acid, and a cross-linking adduct. Stable adducts derived from formylacetic acid were detected in all patients exposed to the drug. Importantly, analysis of hapten–protein adducts formed in the cell culture medium revealed that the highly drug-specific T-cell responses were likely driven by the markedly different haptenic structures formed by these two drugs. In this study, the unique haptenic structures on albumin in patients formed by amoxicillin and clavulanic acid have been characterized and shown to function as chemically distinct antigens which can stimulate separate, specific T-cell clones.Keywords
Funding Information
- Medical Research Council (MR/L006758/1)
This publication has 27 references indexed in Scilit:
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II AllelesGastroenterology, 2011
- Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injuryJournal of Hepatology, 2010
- Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United StatesGastroenterology, 2008
- Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in ItalyJournal of Antimicrobial Chemotherapy, 2007
- Determinants of the clinical expression of amoxicillin‐clavulanate hepatotoxicityHepatology, 2006
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year PeriodGastroenterology, 2005
- Co-amoxiclav jaundice: clinical and histological features and HLA class II associationGut, 2000
- HLA association of amoxicillin-clavulanate–induced hepatitisGastroenterology, 1999
- Risk of Acute Liver Injury Associated With the Combination of Amoxicillin and Clavulanic AcidArchives of internal medicine (1960), 1996
- Cholestatic hepatitis related to quinolones: a report of two casesJournal of Hepatology, 1995